Literature DB >> 8459893

Allergic cross-reactivity to teicoplanin and vancomycin.

A Davenport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8459893     DOI： 10.1159/000187266

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

Review 1.  Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

Authors:  C M Spencer; H M Bryson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

Review 2.  A risk-benefit assessment of teicoplanin in the treatment of infections.

Authors:  F de Lalla; A Tramarin
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

3.  A case of hypersensitivity syndrome to both vancomycin and teicoplanin.

Authors:  Hyouk-Soo Kwon; Yoon-Seok Chang; Yi-Yeong Jeong; Sang-Min Lee; Woo-Jung Song; Hong-Bin Kim; Yoon-Keun Kim; Sang-Heon Cho; You-Young Kim; Kyung-Up Min
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 4.  Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D H Peters
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.